Ignite Biomedical and Liquid Biosciences Partner to Discover First-in-Class Drug Targets
No approved drug, clinical-stage asset, or competing research program targets the mechanisms that Liquid's Emerge platform identifies. FRAMINGHAM, MA /...
Neurology
Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy
– Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population,...
Senior Care Authority Kicks off Alzheimer’s and Brain Awareness Month with Six Science-Backed Habits That May Help Reduce Dementia Risk
Most dementia risk may be more controllable than families realizeIncline Village, Nevada--(Newsfile Corp. - June 4, 2026) - An estimated...
Acute Patients Embrace At-Home Monitoring, Emphasizing Device Comfort and Ease of Use as Driving Adoption
Vivalink's latest survey highlights key drivers for patient compliance and retention in acute remote care programsNew Vivalink survey finds acute...
Cordica Medical Acquires RapidWerks Micro-Molding
Expanding Cordica Medical's precision capabilities for the miniaturization of next-generation medical devices KNOXVILLE, TN / ACCESS Newswire / June 4,...
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Ready-to-use romidepsin formulation; offers a more convenient alternative to lyophilized powder requiring reconstitutionCompetitive Generic Therapy approval provides 180 days of...
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Designation is supported by an exploratory analysis from the Phase 1b study showing that some children with SMA previously treated...
Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
Cooper University Health Care Announces Major New $300 Million Gloucester Township Campus
State-of-the-art outpatient facility will expand access to advanced specialty careBlackwood, New Jersey--(Newsfile Corp. - June 3, 2026) - Cooper University...
Joyce A. Cramer to Receive Lifetime Accelerator Award for Transformative Contributions to Clinical Research and Epilepsy Innovation
BOWIE, Md., June 3, 2026 /PRNewswire/ -- The Epilepsy Foundation of America is proud to announce that Joyce A. Cramer...
Lundbeck Partners with Cradle to Discover and Optimize Brain Disorder Treatments
Collaboration's initial focus will focus on two antibody programs targeting CNS diseases VALBY, Denmark and AMSTERDAM, June 3, 2026 /PRNewswire/ --...
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
83% of dermatomyositis patients in the Phase 1/2 RESET-Myositis study would have met the registrational primary endpoint; all these patients...
NATIONAL MS SOCIETY, COMMUNITY PARTNERS SHOW EARLY IMPACT IN CLOSING MULTIPLE SCLEROSIS CARE GAPS IN SOUTH CAROLINA
Partnerships with the Medical University of South Carolina, Prisma Health, and the South Carolina Community Health Worker Association drive toward...
NATIONAL MS SOCIETY, COMMUNITY PARTNERS SHOW EARLY IMPACT IN CLOSING MULTIPLE SCLEROSIS CARE GAPS IN SOUTH CAROLINA
Partnerships with the Medical University of South Carolina, Prisma Health, and the South Carolina Community Health Worker Association drive toward...
Helix Builds North America’s Largest Available Linked Clinico-Genomic Dataset, Launches AI Tools to Accelerate Discovery
• Helix GenoSphere surpasses 500,000 clinico-genomic linked records, setting a new benchmark for scale in multi-modal research• Helix launches AI cohort...
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline
Significant Deleveraging: Total liabilities decreased by $4.5 million, or 9.6%, quarter-over-quarter, while stockholders' equity increased 7.6%Landmark Financing: R&D division in...
Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD
– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of War – KENMORE, N.Y,...
Evotec Appoints Rui Wang as Head of Global In Silico and AI
HAMBURG, DE / ACCESS Newswire / June 2, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced the appointment of...
Privia Health Enters New Jersey
Represents 25th State in National Primary Care-Centric Care Delivery NetworkARLINGTON, Va., May 27, 2026 (GLOBE NEWSWIRE) -- Privia Health Group,...
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of...